The peripheral blood of Aβ binding RBC as a biomarker for diagnosis of Alzheimer's disease.

Background: in vitro, it has been reported that amyloid β (Aβ) is bound to red blood cells (RBCs) and this process damages the red cell. Also, a possible relationship between RBCs and Alzheimer's disease (AD) is supported by the findings of RBC impairment in AD. Therefore, Aβ fibrils bounding RBC ar...

Descripción completa

Detalles Bibliográficos
Publicado en:Age & Ageing Vol. 44; no. 3; pp. 458 - 465
Autores principales: JIE LAN, JINPING LIU, ZHUO ZHAO, RONG XUE, NAN ZHANG, PEILAN ZHANG, PENG ZHAO, FANG ZHENG, XUGUO SUN
Formato: Artículo
Publicado: Oxford University Press / USA May2015
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=102711372&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 102711372
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00020729
        AGA
      jtl: Age & Ageing
      issn: 00020729
      maglogo: N
    pubinfo:
      dt: May2015
      vid: 44
      iid: 3
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        102711372
        10.1093/ageing/afv009
      ppf: 458
      ppct: 7
      formats:
      tig:
        atl: The peripheral blood of Aβ binding RBC as a biomarker for diagnosis of Alzheimer's disease.
      aug:
        au:
          JIE LAN
          JINPING LIU
          ZHUO ZHAO
          RONG XUE
          NAN ZHANG
          PEILAN ZHANG
          PENG ZHAO
          FANG ZHENG
          XUGUO SUN
        affil:
          School of Medical Laboratory, Tianjin Medical University, Tianjin, Tianjin 300203, China
          Department of Neurology, Tianjin Medical University Hospital, Tianjin, Tianjin, China
          Technical Center for Safety of Industrial Products of Tianjin Entry-Exit Inspection and Quarantine Bureau, Tianjin, Tianjin, China
          Department of Neurology, Tianjin Huanhu Hospital, Tianjin, Tianjin, China
      su:
        Alzheimer's disease diagnosis
        Erythrocytes
        Biomarkers
        Biological assay
        Fluorescent antibody technique
        Neuropsychological tests
        Microscopy
        Proteins
        Research funding
        Data analysis software
        Descriptive statistics
        Fluorescent dyes
      sug:
        subj:
          Synthetic Dye and Pigment Manufacturing
          Alzheimer's disease diagnosis
          Erythrocytes
          Biomarkers
          Biological assay
          Fluorescent antibody technique
          Neuropsychological tests
          Microscopy
          Proteins
          Research funding
          Data analysis software
          Descriptive statistics
          Fluorescent dyes
      keyword:
        Aβ fibrils
        Alzheimer's disease
        older people
        red blood cells
        thioflavin T
        Aβ fibrils
        Alzheimer's disease
        older people
        red blood cells
        thioflavin T
      ab: Background: in vitro, it has been reported that amyloid β (Aβ) is bound to red blood cells (RBCs) and this process damages the red cell. Also, a possible relationship between RBCs and Alzheimer's disease (AD) is supported by the findings of RBC impairment in AD. Therefore, Aβ fibrils bounding RBC are of great interest as potential biomarkers. Methods: in this study, we focused on Aβ amyloid fibrils and/or aggregation on the peripheral RBC from 50 subjects with AD and 50 healthy controls (HCs) through thioflavin T (ThT) staining followed by immunofluorescence assay to confirm the presence of Aβ amyloid fibrils and/or aggregation on the RBC. Then we optimised fluorescence staining and imaging conditions and analysed the images obtained by image processing software. Results: we have analysed RBC morphology in blood from 50 subjects with AD and 50 HCs found that 16.8% of the RBCs are elongated as compared with 6.7% in normal controls (P < 0.01), and there is a negative correlation between the two parameters (P < 0.05). Our study showed that 98% of AD peripheral RBCs were amyloid binding-positive (ranging from 2 to 30%), while only 38% that of RBCs (ranging from 2 to 3.4%) were in HCs. We also found four modified morphologies of RBCs triggered by Aβ binding, which may serve as an ancillary investigation and indicate the progression of AD. Conclusion: we first directly prove the existence of Aβ binding RBCs in peripheral blood. In addition, we observed new modified morphologies of RBC triggered by Aβ binding, all of those can serve as a biomarker for the diagnosis and progression of AD.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N